超敏C-反应蛋白的研究现状及临床应用(5)
参考文献：
1． Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am, 2000,84:149-161.
2． Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation, 2001,104:63-67.
3． Libby P, Ridker PM. Novel inflammatory markers of coronary risk.
Circulation,1999,100:1148-1150.
4． Gomes MC. C-reactive protein: a new golden marker of caidiovascular risk. Rev Port Cardiol, 2002,21:1329-1346.
5． Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem, 2001.47:403-411.
6． Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem, 1999,45:2136-2141.
7． Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein : an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci, 2002,13:14-17.
8． Roivainen M, Vilk-kajander M, Palosuo T, et al. Infection, inflammation, and the risk of cornary heart disease. Circulation, 2000,101:252-257.
9． Ridker PM, Buring JE, Shih J et al. Prospective study of C-reactive protein and the eisk of future cardiovascular events among apparently healthy women. Circulation,1998,98:731-733.
10． Kuiier LH, Tracy PP, Shaten J, et al. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-contral study. Am J Epidemiol, 1996,144:537-547.
11． Sakkinen P, Abbott RD, Curb JD, et al. C-reactive protein and incident myocardial infarction in Japanese American men. Circulation,1999,99: 1121.
12． Liuzzo G, Biasucci LM, Gallimore JR, et al. the prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med,1994,331:417-424.
13． Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol, 1998,31:1460-1465.
14． Whicher J, Rifai N, Biasucci LM. Marker of the acute phase response in cardiovascular disease: an update. Clin Chem. Lab Med, 2001,39:1054-1064.
15． Cushman M, Arnold AM, Kuller LH, et al. C-reactive protein and risks of myocardial infarction, stroke and death in an elderly cohort. Circulation, 1999,98:1108.
16． Curb JD, Abbott RD, Rodriguez BL, et al. The relationship of C-reactive protein to the incidence of thromboembolic stroke . Circulation, 1999,99:1108.
17． Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem, 2001, 47: 418-425.
18． Rifai N. C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention. Cardiovasc Toxicol, 2001, 1: 153-157.
19． Futterman LG, Lemberg Ll. High-sensitivity C-reactive protein id the most effective prognostic measurement of acute coronary events. Am J Crit Care,2002,11:482-486.
20． Ridker PM, Hennekens CH, Buring IE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med,2000,342:836-843.
21． Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem.,2001,47:28-30.
22． Rosenson RS, Koenig W. High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Curr Opin Cardiol,2002,2002,17:325-331.
23． Hutchinson WL, Koenig W, Frolich M, et al. Immunoradiomatric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem.,2000,46:934-938.
24． Chenillot O, Henny J, Steinmetz J, et al. High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem.,2000,38:1003-1011.
25． Visser M, Bouter LM, Mcquillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc,1999,282:2131-2135.
